- Abstract Number: 087
A Growing Problem: Factors Associated with Growth Disturbances in Juvenile Localized Scleroderma
- Abstract Number: 018
Abnormal Cortical Grey Matter, White Matter and Subcortical Grey Matter Morphometry is Associated with Disease Features and Quality of Life in Patients with Craniofacial Localized Scleroderma
- Abstract Number: 096
Acute Care Utilization in New-Onset Childhood Systemic Lupus Erythematosus: Insights from a Pilot Study
- Abstract Number: 140
Adalimumab Tapering is Associated with Short-term, but not Long-term, Advantages for Well-controlled Juvenile Idiopathic Arthritis: A Retrospective Cohort Study using the CARRA Registry
- Abstract Number: 141
Age and Activity-Dependent Differences in Intraocular Immune Profile of Chronic Autoimmune Uveitis
- Abstract Number: 006
Age Matters: Clinical Profile and IVIG Responsiveness in infants with Kawasaki Disease. A multicentric retrospective analysis of 36 patients from North India
- Abstract Number: 132
AI-Assisted Body-Region Recognition for Localized Scleroderma: the 1st Step in Automated LoSCAT scoring
- Abstract Number: 027
An Examination of Brain-age-related Deviations from Normative Neurodevelopmental Trajectory in Children with Childhood-Onset Systemic Lupus Erythematosus
- Abstract Number: 103
Anifrolumab Use in Youngsters with Rheumatic Conditions: Case Series and a Review of the Evidence Base
- Abstract Number: 089
Anti-CD19 CAR-T Cell Therapy for the Treatment of Severe/Refractory Pediatric Autoimmune Diseases: A Single-Center Case Series
- Abstract Number: 046
Antibiotic Exposure and New Diagnosis of Juvenile Idiopathic Arthritis: A Nested Case-Control Study in a Large US Population
- Abstract Number: 040
Antiphospholipid Antibody-Mediated Disease: Clinical Characteristics and Outcomes of Catastrophic Antiphospholipid Syndrome and Lupus Anticoagulant Hypoprothrombinemia in a Single Center Pediatric Cohort
- Abstract Number: 086
APOL1 Focal Segmental Glomerulosclerosis Requiring Renal Transplant, the Burden of Childhood onset Autoimmune and Autoinflammatory Disease
- Abstract Number: 028
Are You Positive About this Positive ANA Referral? Outcomes for ANA Based Referrals to Pediatric Rheumatology and Subsequent Disease Development
- Abstract Number: 054
Assessing Completion of Healthcare Transition: A Retrospective Review of Provider Acknowledgment Following Pediatric Rheumatology Transfer
Pediatric Rheumatology Symposium 2026
March 18-21, 2026. Minneapolis, MN.